A proteogenomic analysis of the adiposity colorectal cancer relationship identifies GREM1 as a probable mediator.
(2024 Dec 16)
Int J Epidemiol 54(1):
Lee MA, Hatcher CA, Hazelwood E, Goudswaard LJ, Tsilidis KK, Vincent EE, Martin RM, Smith-Byrne K, Brenner H, Cheng I, Kweon SS, Le Marchand L, Newcomb PA, Schoen RE, Peters U, Gunter MJ, Van Guelpen B, Murphy N

Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk.
(2025 Jan 3)
JNCI Cancer Spectr 9(1):
MacInnis RJ, Jenkins MA, Milne RL, John EM, Daly MB, Andrulis IL, Colonna SV, Phillips KA, kConFab Investigators, Le Marchand L, Newcomb PA, Phipps AI, Schmit SL, Macrae FA, Buchanan DD, Gallinger S, Pai RK, Samadder NJ, Giles GG, Southey MC, Hopper JL, Terry MB

Causal debiasing for unknown bias in histopathology-A colon cancer use case.
(2024)
PLoS One 19(11): e0303415
Correa-Medero RL, Pai R, Ebare K, Buchanan DD, Jenkins MA, Phipps AI, Newcomb PA, Gallinger S, Grant R, Le Marchand L, Banerjee I

Characterization of Additive Gene-environment Interactions For Colorectal Cancer Risk.
(2025 Jan 1)
Epidemiology 36(1): 126-138
Thomas CE, Lin Y, Kim M, Kawaguchi ES, Qu C, Um CY, Lynch BM, Van Guelpen B, Tsilidis K, Carreras-Torres R, van Duijnhoven FJB, Sakoda LC, Campbell PT, Tian Y, Chang-Claude J, Bézieau S, Budiarto A, Palmer JR, Newcomb PA, Casey G, Le Marchandz L, Giannakis M, Li CI, Gsur A, Newton C, Obón-Santacana M, Moreno V, Vodicka P, Brenner H, Hoffmeister M, Pellatt AJ, Schoen RE, Dimou N, Murphy N, Gunter MJ, Castellví-Bel S, Figueiredo JC, Chan AT, Song M, Li L, Bishop DT, Gruber SB, Baurley JW, Bien SA, Conti DV, Huyghe JR, Kundaje A, Su YR, Wang J, Keku TO, Woods MO, Berndt SI, Chanock SJ, Tangen CM, Wolk A, Burnett-Hartman A, Wu AH, White E, Devall MA, Díez-Obrero V, Drew DA, Giovannucci E, Hidaka A, Kim AE, Lewinger JP, Morrison J, Ose J, Papadimitriou N, Pardamean B, Peoples AR, Ruiz-Narvaez EA, Shcherbina A, Stern MC, Chen X, Thomas DC, Platz EA, Gauderman WJ, Peters U, Hsu L

Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers.
(2024 Aug 15)
J Natl Cancer Inst Monogr 2024(66): 202-217
Ellison GL, Helzlsouer KJ, Rosenfield SM, Kim Y, Ashare RL, Blaes AH, Cullen J, Doran N, Ebbert JO, Egan KM, Heffner JL, Lee RT, McClure EA, McDaniels-Davidson C, Meghani SH, Newcomb PA, Nugent S, Hernandez-Ortega N, Salz T, Vidot DC, Worster B, Zylla DM